Patents by Inventor Peter Stuart Ringrose

Peter Stuart Ringrose has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4100275
    Abstract: Compositions having antibiotic properties containing as antibiotic potentiators peptides of the formula ##STR1## wherein R.sup.1 represents a hydrogen atom or a lower alkyl, lower cycloalkyl, (lower cycloalkyl)-(lower alkyl), aryl or aryl(lower alkyl) group (said group being optionally substituted as the case may require by one or more amino, hydroxy, thio, methylthio, carboxy or guanidino groups so as to form the characterizing group of a naturally occurring L .alpha.-amino acid); R.sup.2 and R.sup.3 each represent the characterizing group of an .alpha.-amino acid of the type normally found in proteins with the proviso that R.sup.3 cannot represent a hydrogen atom when n is zero and R.sup.1 is a hydrogen atom or the phenyl group; R.sup.4 represents a hydroxy or methyl group; n stands for zero, 1, 2 or 3; and single asterisks denote that the configuration at the carbon atom so-marked is L when R.sup.2 or R.sup.
    Type: Grant
    Filed: July 21, 1976
    Date of Patent: July 11, 1978
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Frank Ratcliffe Atherton, Michael John Hall, Cedric Herbert Hassall, Peter Stuart Ringrose, Robert Wilson Lambert
  • Patent number: 4016148
    Abstract: The present disclosure relates to peptide derivatives. More particularly, the disclosure is concerned with peptide derivatives of phosphonic and phosphinic acids, a process for the manufacture thereof and pharmaceutical preparations containing same.
    Type: Grant
    Filed: January 19, 1976
    Date of Patent: April 5, 1977
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Frank Ratcliffe Atherton, Michael John Hall, Cedric Herbert Hassall, Peter Stuart Ringrose, Robert Wilson Lambert